Shares of Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $59.46, but opened at $64.49. Novozymes A/S shares last traded at $64.71, with a volume of 788 shares trading hands.
Analyst Ratings Changes
Separately, Zacks Research downgraded Novozymes A/S from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 25th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, Novozymes A/S has a consensus rating of “Buy”.
Check Out Our Latest Report on NVZMY
Novozymes A/S Price Performance
Novozymes A/S Cuts Dividend
The business also recently announced a dividend, which was paid on Thursday, September 11th. Shareholders of record on Wednesday, September 3rd were given a $0.1856 dividend. This represents a yield of 88.0%. The ex-dividend date of this dividend was Tuesday, September 2nd. Novozymes A/S’s payout ratio is 21.76%.
Novozymes A/S Company Profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Read More
- Five stocks we like better than Novozymes A/S
- Using the MarketBeat Dividend Yield Calculator
- Netflix Stock Split Explained: What It Means for Investors
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- SoundHound Beat Earnings & Dropped—Here’s What Wall Street Missed
- What is a Dividend King?Â
- AI Trade Over? Datadog Results Say It’s Gaining Momentum
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
